OPK
OPKO Health, Inc. · Healthcare · Medical - Diagnostics & Research
Momentum inputs (comparable managers):
holder breadth -8.3% ·
share flow +17.5% ·
net new positions -9.1%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 83 | -5 | 114.41M | $171.44M | +3 | −8 |
| Q1 2026 | 91 | +2 | 116.06M | $132.34M | +8 | −6 |
| Q4 2025 | 88 | 0 | 132.71M | $167.24M | +1 | −1 |
| Q3 2025 | 15 | -2 | 100.01M | $155.02M | — | −3 |
| Q2 2025 | 15 | 0 | 96.47M | $127.34M | +2 | −2 |
| Q1 2025 | 12 | +1 | 38.88M | $64.54M | +2 | −1 |
| Q4 2024 | 11 | -1 | 30.02M | $44.13M | — | −1 |
| Q3 2024 | 11 | +1 | 16.46M | $24.53M | +1 | — |
| Q2 2024 | 10 | — | 13.40M | $16.75M | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passive) | 9.07M | — | $13.34M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 8.39M | +0.1% | $12.33M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 8.39M | +0.1% | $12.33M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | Millennium Management ✦ | 4.59M | +85.3% | $6.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | Citadel Advisors ✦ | 3.21M | +28.3% | $4.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Citadel Advisors ✦ | 3.21M | +28.3% | $4.72M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 7 | Two Sigma Investments ✦ | 1.65M | +136.1% | $2.42M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 8 | Norges Bank ✦ (passive) | 1.13M | 0.0% | $1.66M | 0.0% | Held | 3 | SEC ↗ |
| 9 | Marshall Wace ✦ | 921.49K | +856.5% | $1.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 10 | Marshall Wace ✦ | 921.49K | +856.5% | $1.35M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | T. Rowe Price ✦ | 455.52K | +4.2% | $670,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 283.92K | +268.0% | $417,360 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | AQR Capital Management ✦ | 283.92K | +268.0% | $417,360 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 283.92K | +268.0% | $417,360 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 283.92K | +268.0% | $417,360 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | GAMCO Investors ✦ | 175.00K | 0.0% | $257,250 | 0.0% | Held | 3 | SEC ↗ |
| 17 | Renaissance Technologies ✦ | 145.98K | -68.2% | $214,586 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Gotham Asset Management | $58,862 | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 231 holders, 200.30M shares, $226.79M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.